• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RHPN1-AS1 通过海绵吸附 miR-485-5p 和释放 TPX2 mRNA 促进卵巢癌发生。

RHPN1‑AS1 promotes ovarian carcinogenesis by sponging miR‑485‑5p and releasing TPX2 mRNA.

机构信息

Department of Gynaecology and Obstetrics, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, P.R. China.

出版信息

Oncol Rep. 2021 Jun;45(6). doi: 10.3892/or.2021.8062. Epub 2021 Apr 28.

DOI:10.3892/or.2021.8062
PMID:33907841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8082340/
Abstract

Long non‑coding RNAs (lncRNAs) play a crucial role in cancer development. However, researchers have yet to identify the underlying association between lncRNAs and ovarian cancer (OC). The aim of the present study was to examine the effect of lncRNA RHPN1‑AS1 (RHPN1‑AS1) on OC cells and tissues. Reverse transcriptase‑quantitative PCR (RT‑qPCR) was utilized to quantify RHPN1‑AS1, miR‑485‑5p, and mRNA expression in samples with OC. Luciferase‑reporter assay, RNA immunoprecipitation (RIP) assay, and RNA pull‑down assay were then employed to validate the target relationship among RHPN1‑AS1, miR‑485‑5p and . Cell Counting Kit‑8, BrdU, wound‑healing, cell‑adhesion, and flow cytometry assays were also employed to assess cell viability, proliferation, migration, adhesion and apoptosis, respectively, in SKOV3 and OVCAR3 cell lines. Findings revealed that RHPN1‑AS1 demonstrated a higher expression level in OC cell lines and tissues. In addition, RHPN1‑AS1 enhanced the adhesion, proliferation and migration of OC cell lines but decreased apoptosis of OC cells. It was also observed that the relationship between RHPN1‑AS1 and miR‑485‑5p was negative and that RHPN1‑AS1 could sponge miR‑485‑5p to regulate the proliferation, apoptosis, adhesion, and migration abilities of OC cells. Moreover, was targeted by miR‑485‑5p and was significantly overexpressed in OC cell lines and tissues. Experimental investigations also revealed that promoted the proliferation, adhesion, and migration of OC cells but suppressed the apoptosis of SKOV3 and OVCAR3 cells. In summary, RHPN1‑AS1 played a tumor promotive role by sponging miR‑485‑5p to increase expression in OC tumorigenesis.

摘要

长链非编码 RNA(lncRNA)在癌症发展中发挥着关键作用。然而,研究人员尚未确定 lncRNA 与卵巢癌(OC)之间的潜在关联。本研究旨在研究 lncRNA RHPN1-AS1(RHPN1-AS1)对 OC 细胞和组织的影响。逆转录-定量 PCR(RT-qPCR)用于定量 OC 样本中 RHPN1-AS1、miR-485-5p 和 mRNA 的表达。然后使用荧光素酶报告基因检测、RNA 免疫沉淀(RIP)测定和 RNA 下拉测定来验证 RHPN1-AS1、miR-485-5p 和 之间的靶标关系。细胞计数试剂盒-8(CCK-8)、BrdU、划痕愈合、细胞黏附以及流式细胞术实验也用于评估 SKOV3 和 OVCAR3 细胞系中的细胞活力、增殖、迁移、黏附和凋亡。结果表明,RHPN1-AS1 在 OC 细胞系和组织中表达水平较高。此外,RHPN1-AS1 增强了 OC 细胞系的黏附、增殖和迁移,但降低了 OC 细胞的凋亡。还观察到 RHPN1-AS1 与 miR-485-5p 呈负相关,并且 RHPN1-AS1 可以吸附 miR-485-5p 来调节 OC 细胞的增殖、凋亡、黏附和迁移能力。此外, 是 miR-485-5p 的靶标,在 OC 细胞系和组织中显著过表达。实验研究还表明, 促进了 OC 细胞的增殖、黏附和迁移,但抑制了 SKOV3 和 OVCAR3 细胞的凋亡。综上所述,RHPN1-AS1 通过吸附 miR-485-5p 增加 OC 肿瘤发生中的 表达,发挥肿瘤促进作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/8082340/88eb7bbb0f7a/or-45-06-8062-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/8082340/bc137661d266/or-45-06-8062-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/8082340/e29c4272a715/or-45-06-8062-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/8082340/67c4706a0cca/or-45-06-8062-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/8082340/58f195f45070/or-45-06-8062-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/8082340/c3a5239b3ebe/or-45-06-8062-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/8082340/2f9843193718/or-45-06-8062-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/8082340/88eb7bbb0f7a/or-45-06-8062-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/8082340/bc137661d266/or-45-06-8062-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/8082340/e29c4272a715/or-45-06-8062-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/8082340/67c4706a0cca/or-45-06-8062-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/8082340/58f195f45070/or-45-06-8062-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/8082340/c3a5239b3ebe/or-45-06-8062-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/8082340/2f9843193718/or-45-06-8062-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/8082340/88eb7bbb0f7a/or-45-06-8062-g06.jpg

相似文献

1
RHPN1‑AS1 promotes ovarian carcinogenesis by sponging miR‑485‑5p and releasing TPX2 mRNA.RHPN1-AS1 通过海绵吸附 miR-485-5p 和释放 TPX2 mRNA 促进卵巢癌发生。
Oncol Rep. 2021 Jun;45(6). doi: 10.3892/or.2021.8062. Epub 2021 Apr 28.
2
RHPN1‑AS1 promotes ovarian carcinogenesis by sponging miR‑6884‑5p thus releasing TOP2A mRNA.RHPN1-AS1 通过海绵吸附 miR-6884-5p 从而释放 TOP2A mRNA 促进卵巢癌发生。
Oncol Rep. 2021 Oct;46(4). doi: 10.3892/or.2021.8172. Epub 2021 Aug 20.
3
TPX2 promotes cell proliferation and migration via PLK1 in OC.TPX2 通过 PLK1 促进 OC 中的细胞增殖和迁移。
Cancer Biomark. 2018;22(3):443-451. doi: 10.3233/CBM-171056.
4
Long non‑coding RNA LINC01224 promotes cell proliferation and inhibits apoptosis by regulating AKT3 expression via targeting miR‑485‑5p in endometrial carcinoma.长链非编码RNA LINC01224通过靶向miR-485-5p调控AKT3表达促进子宫内膜癌细胞增殖并抑制其凋亡。
Oncol Rep. 2021 Sep;46(3). doi: 10.3892/or.2021.8137. Epub 2021 Jul 19.
5
Upregulation of long noncoding RNA XIST has anticancer effects on ovarian cancer through sponging miR-106a.长链非编码 RNA XIST 的上调通过海绵吸附 miR-106a 对卵巢癌具有抗癌作用。
Hum Cell. 2021 Mar;34(2):579-587. doi: 10.1007/s13577-020-00469-w. Epub 2021 Jan 5.
6
Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p.Lnc00908 通过调控 microRNA-495-5p 促进卵巢癌的发展。
Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1388-1396. doi: 10.26355/eurrev_201902_17095.
7
circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.环状 CSPP1 通过作为 miR-1236-3p 的海绵吸附子促进卵巢癌细胞的增殖、侵袭和迁移。
Biomed Pharmacother. 2019 Jun;114:108832. doi: 10.1016/j.biopha.2019.108832. Epub 2019 Apr 11.
8
LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.LINC-PINT 通过靶向 miR-374a-5p 抑制卵巢癌细胞的增殖、迁移和侵袭。
Cell Biochem Funct. 2020 Dec;38(8):1089-1099. doi: 10.1002/cbf.3565. Epub 2020 Jul 7.
9
lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.长链非编码 RNA MEG3 通过海绵吸附 miR-219a-5p 并调节 EGFR 来修饰卵巢癌细胞的上皮-间充质转化。
J Cell Biochem. 2019 Oct;120(10):17709-17722. doi: 10.1002/jcb.29037. Epub 2019 Jun 3.
10
Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.长链非编码 RNA ATB 通过与 EZH2 结合介导组蛋白 H3 赖氨酸 27 三甲基化促进卵巢癌细胞发生。
J Cell Mol Med. 2021 Jan;25(1):37-46. doi: 10.1111/jcmm.15329. Epub 2020 Dec 18.

引用本文的文献

1
Latest Update on lncRNA in Epithelial Ovarian Cancer-A Scoping Review.上皮性卵巢癌中长链非编码RNA的最新进展——一项综述。
Cells. 2025 Apr 7;14(7):555. doi: 10.3390/cells14070555.
2
Competing endogenous RNA networks in ovarian cancer: from bench to bedside.卵巢癌中的竞争性内源性RNA网络:从实验台到病床边
EXCLI J. 2025 Jan 7;24:86-112. doi: 10.17179/excli2024-7827. eCollection 2025.
3
METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway.METTL3 介导的长非编码 RNA RHPN1-AS1 的 m6A 修饰通过激活 PI3K/AKT 通路增强卵巢癌细胞对顺铂的耐药性。

本文引用的文献

1
RHPN1-AS1 promotes cell proliferation and migration via miR-665/Akt3 in ovarian cancer.RHPN1-AS1 通过 miR-665/Akt3 促进卵巢癌细胞的增殖和迁移。
Cancer Gene Ther. 2021 Feb;28(1-2):33-41. doi: 10.1038/s41417-020-0180-0. Epub 2020 May 27.
2
LncRNA RHPN1-AS1 accelerates proliferation, migration, and invasion via regulating miR-485-5p/BSG axis in hepatocellular carcinoma.长链非编码RNA RHPN1-AS1通过调控miR-485-5p/BSG轴促进肝细胞癌的增殖、迁移和侵袭。
Naunyn Schmiedebergs Arch Pharmacol. 2020 Dec;393(12):2543-2551. doi: 10.1007/s00210-020-01889-z. Epub 2020 May 21.
3
miR-485-3p suppresses colorectal cancer via targeting TPX2.
J Clin Lab Anal. 2022 Dec;36(12):e24761. doi: 10.1002/jcla.24761. Epub 2022 Nov 6.
4
Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies.靶向 Xklp2(TPX2)蛋白在人类恶性肿瘤中致癌作用的综合分析。
Dis Markers. 2022 Oct 18;2022:7571066. doi: 10.1155/2022/7571066. eCollection 2022.
微小RNA-485-3p通过靶向TPX2抑制结直肠癌。
Bratisl Lek Listy. 2020;121(4):302-307. doi: 10.4149/BLL_2020_048.
4
Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.长非编码 RNA RHPN1-AS1 通过作为 ceRNA 对抗 miR-596 并上调 LETM1 促进卵巢癌的发生和转移。
Aging (Albany NY). 2020 Mar 12;12(5):4558-4572. doi: 10.18632/aging.102911.
5
Long noncoding RNA RHPN1-AS1 promotes colorectal cancer progression via targeting miR-7-5p/OGT axis.长链非编码RNA RHPN1-AS1通过靶向miR-7-5p/OGT轴促进结直肠癌进展。
Cancer Cell Int. 2020 Feb 18;20:54. doi: 10.1186/s12935-020-1110-9. eCollection 2020.
6
STAT1-induced upregulation of lncRNA RHPN1-AS1 predicts a poor prognosis of hepatocellular carcinoma and contributes to tumor progression via the miR-485/CDCA5 axis.STAT1诱导的lncRNA RHPN1-AS1上调预示着肝细胞癌的不良预后,并通过miR-485/CDCA5轴促进肿瘤进展。
J Cell Biochem. 2020 Dec;121(12):4741-4755. doi: 10.1002/jcb.29689. Epub 2020 Feb 17.
7
Retracted: Long noncoding RNA RHPN1-AS1, induced by KDM5B, is involved in breast cancer via sponging miR-6884-5p.撤回:由 KDM5B 诱导的长非编码 RNA RHPN1-AS1 通过海绵吸附 miR-6884-5p 参与乳腺癌的发生。
J Cell Biochem. 2023 Jul;124(7):1064. doi: 10.1002/jcb.29645. Epub 2020 Jan 31.
8
The positive feedback loop of RHPN1-AS1/miR-1299/ETS1 accelerates the deterioration of gastric cancer.RHPN1-AS1/miR-1299/ETS1 的正反馈环加速了胃癌的恶化。
Biomed Pharmacother. 2020 Apr;124:109848. doi: 10.1016/j.biopha.2020.109848. Epub 2020 Jan 23.
9
circAMOTL1 Motivates AMOTL1 Expression to Facilitate Cervical Cancer Growth.环状AMOTL1促进AMOTL1表达以促进宫颈癌生长。
Mol Ther Nucleic Acids. 2020 Mar 6;19:50-60. doi: 10.1016/j.omtn.2019.09.022. Epub 2019 Sep 30.
10
RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.RHPN1-AS1 通过调控 miR-596/IGF2BP2 轴促进肝癌进展。
Curr Pharm Des. 2020;25(43):4630-4640. doi: 10.2174/1381612825666191105104549.